Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 10051 | 1032 | 32.8 | 64% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1701 | 6131 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ISOLATED LIMB PERFUSION | Author keyword | 152 | 72% | 11% | 118 |
| 2 | ISOLATED LIMB INFUSION | Author keyword | 103 | 93% | 4% | 39 |
| 3 | ISOLATED HEPATIC PERFUSION | Author keyword | 42 | 83% | 2% | 24 |
| 4 | HYPERTHERMIC ISOLATED LIMB PERFUSION | Author keyword | 30 | 84% | 2% | 16 |
| 5 | MELPHALAN | Author keyword | 25 | 18% | 12% | 123 |
| 6 | LIMB PERFUSION | Author keyword | 24 | 68% | 2% | 21 |
| 7 | REGIONAL CHEMOTHERAPY | Author keyword | 21 | 32% | 5% | 55 |
| 8 | ISOLATION PERFUSION | Author keyword | 21 | 75% | 1% | 15 |
| 9 | PERCUTANEOUS HEPATIC PERFUSION | Author keyword | 18 | 89% | 1% | 8 |
| 10 | IN TRANSIT MELANOMA | Author keyword | 17 | 79% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ISOLATED LIMB PERFUSION | 152 | 72% | 11% | 118 | Search ISOLATED+LIMB+PERFUSION | Search ISOLATED+LIMB+PERFUSION |
| 2 | ISOLATED LIMB INFUSION | 103 | 93% | 4% | 39 | Search ISOLATED+LIMB+INFUSION | Search ISOLATED+LIMB+INFUSION |
| 3 | ISOLATED HEPATIC PERFUSION | 42 | 83% | 2% | 24 | Search ISOLATED+HEPATIC+PERFUSION | Search ISOLATED+HEPATIC+PERFUSION |
| 4 | HYPERTHERMIC ISOLATED LIMB PERFUSION | 30 | 84% | 2% | 16 | Search HYPERTHERMIC+ISOLATED+LIMB+PERFUSION | Search HYPERTHERMIC+ISOLATED+LIMB+PERFUSION |
| 5 | MELPHALAN | 25 | 18% | 12% | 123 | Search MELPHALAN | Search MELPHALAN |
| 6 | LIMB PERFUSION | 24 | 68% | 2% | 21 | Search LIMB+PERFUSION | Search LIMB+PERFUSION |
| 7 | REGIONAL CHEMOTHERAPY | 21 | 32% | 5% | 55 | Search REGIONAL+CHEMOTHERAPY | Search REGIONAL+CHEMOTHERAPY |
| 8 | ISOLATION PERFUSION | 21 | 75% | 1% | 15 | Search ISOLATION+PERFUSION | Search ISOLATION+PERFUSION |
| 9 | PERCUTANEOUS HEPATIC PERFUSION | 18 | 89% | 1% | 8 | Search PERCUTANEOUS+HEPATIC+PERFUSION | Search PERCUTANEOUS+HEPATIC+PERFUSION |
| 10 | IN TRANSIT MELANOMA | 17 | 79% | 1% | 11 | Search IN+TRANSIT+MELANOMA | Search IN+TRANSIT+MELANOMA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HYPERTHERMIC ANTIBLASTIC PERFUSION | 102 | 95% | 3% | 35 |
| 2 | REGIONAL ISOLATED PERFUSION | 73 | 89% | 3% | 33 |
| 3 | ISOLATED LIMB PERFUSION | 61 | 32% | 15% | 157 |
| 4 | RECURRENCE FREE INTERVAL | 60 | 100% | 2% | 20 |
| 5 | REGIONAL PERFUSION | 40 | 55% | 5% | 50 |
| 6 | MELPHALAN | 38 | 15% | 23% | 241 |
| 7 | RECURRENT MELANOMA | 32 | 57% | 4% | 38 |
| 8 | ISOLATED REGIONAL PERFUSION | 30 | 84% | 2% | 16 |
| 9 | ISOLATED LIVER PERFUSION | 27 | 78% | 2% | 18 |
| 10 | ISOLATED HEPATIC PERFUSION | 24 | 45% | 4% | 40 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Current uses of isolated limb perfusion in the clinic and a model system for new strategies | 2003 | 129 | 57 | 91% |
| Isolated Limb Perfusion with Melphalan for Melanoma | 2014 | 4 | 54 | 89% |
| TNF-alpha in cancer treatment: Molecular insights, antitumor effects, and clinical utility | 2006 | 212 | 94 | 41% |
| Intra-Lesional Interleukin-2 Therapy for In Transit Melanoma | 2014 | 6 | 29 | 52% |
| Isolated Limb Infusion with Melphalan and Actinomycin D for Melanoma: A Systematic Review | 2014 | 3 | 27 | 85% |
| Treatment of Melanoma Metastases in a Limb by Isolated Limb Perfusion and Isolated Limb Infusion | 2011 | 15 | 58 | 98% |
| Intralesional Therapy With PV-10 (Rose Bengal) for in-Transit Melanoma | 2014 | 7 | 11 | 36% |
| Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: A systematic review | 2013 | 7 | 35 | 77% |
| Clinical applications of TNF-alpha in cancer | 1998 | 175 | 35 | 69% |
| Isolated Limb Infusion: A Review | 2009 | 15 | 53 | 96% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DISCIPLINE ANAESTHET | 14 | 100% | 0.7% | 7 |
| 2 | EXTRA CORPORAL CIRCULAT | 11 | 100% | 0.6% | 6 |
| 3 | SURG METAB SECT | 10 | 38% | 2.0% | 21 |
| 4 | EXPT SURG ONCOL | 6 | 25% | 1.9% | 20 |
| 5 | TRAUMA SURG MUSCULOSKELETAL SURG ONCOL | 3 | 100% | 0.3% | 3 |
| 6 | SURG BRANCH CANC | 3 | 60% | 0.3% | 3 |
| 7 | PLURIDISCIPLINAIRE ONCOL | 2 | 11% | 1.3% | 13 |
| 8 | REG REFERENCE TUSCANY LOCOREG PERFUS THER IE | 1 | 100% | 0.2% | 2 |
| 9 | SURG BC | 1 | 27% | 0.3% | 3 |
| 10 | WEST GERMAN CANC WTZ | 1 | 27% | 0.3% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000118699 | PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS |
| 2 | 0.0000109611 | HEPATIC ARTERIAL INFUSION//HEPATIC ARTERY INFUSION//DEBIRI |
| 3 | 0.0000080667 | SOFT TISSUE SARCOMA//RETROPERITONEAL SARCOMA//RETROPERITONEAL SARCOMAS |
| 4 | 0.0000079334 | THIN MELANOMA//SENTINEL LYMPH NODE//SYDNEY MELANOMA UNIT |
| 5 | 0.0000071741 | MORRIS HEPATOMA 5123//TNF RECEPTORS//ENDOGENOUS TNF ALPHA |
| 6 | 0.0000063751 | BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE |
| 7 | 0.0000061944 | WHOLE BODY HYPERTHERMIA//THERMOCHEMOTHERAPY//INTRACELLULAR PLATINUM UPTAKE |
| 8 | 0.0000048126 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
| 9 | 0.0000038313 | IP PA1//INTEGRATED HOLIST IMMUNOL//BIOTECHNOL MIYAMAE KU |
| 10 | 0.0000038301 | PHLIP//TUMOR ACIDITY//TUMOR PH |